相关实验视频
Updated: Sep 9, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.6K
作为治疗控制策略的神经炎症调节
Alberto Javier Ramos1, Alberto Lazarowski2, Angélica Vega-García3
1Laboratory of Molecular Neuropathology. IBCN University of Buenos Aires-CONICET, School of Medicine, University of Buenos Aires, Argentina.
Seizure
|August 28, 2025
概括
神经炎症导致发作和发作. 针对炎症途径为阿尔茨海默病等疾病提供新的治疗策略和生物标志物.
科学领域:
- 神经科学
- 免疫学
- 神经学
背景情况:
- 神经炎症是发病的重要组成部分.
- 星球细胞和微质细胞介导慢性炎症,有助于生.
- 巨细胞的基因组释放和大脑的基因组神经传递是研究不足的发作机制.
研究的目的:
- 审查神经炎症在中的多方面作用.
- 通过共同的炎症途径探索和阿尔茨海默病之间的联系.
- 讨论针对神经炎症控制发作的新疗法.
主要方法:
- 对有关神经炎症和的现有文献进行了批判性审查.
- 对质细胞,质细胞和组胺在发作中的作用进行分析.
- 作为预后生物标志物的炎症媒介的研究.
- 对和阿尔茨海默病之间的共享炎症机制的审查.
主要成果:
- 星细胞和小质细胞在慢性炎症和发育中起着双重作用.
- 基因组胺和巨细胞的相互作用代表了发作的新机制.
- 炎症媒介可以作为预后和风险的生物标志物.
- 共同的炎症途径,包括反应性星细胞和铁,与和阿尔茨海默病有关.
结论:
- 神经炎症是发作,进展和发作的关键因素.
- 调节神经炎症为治疗提供了有前途的治疗途径.
- 了解共同的炎症途径可能有助于识别和阿尔茨海默病的风险.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608
Antiepileptic Drugs: Sodium Channel Blockers
869
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
869

